Diabetic microangiopathy

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 87, Issue 425, 1998, Pages 31-34

  Dahl Jorgensen K ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Basement membrane thickening; Biochemical changes; Genetic influences; Microangiopathy; Microvascular complications

Indexed keywords

INSULIN;

BLOOD PRESSURE MEASUREMENT; CONFERENCE PAPER; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; INSULIN TREATMENT; PRIORITY JOURNAL; PROTEINURIA; RETINA EXAMINATION;

EID: 0031722685     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb01249.x     Document Type: Conference Paper

References (33)

1. Mortensen HB, Poulgaard P, Hvidøre Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997; 20: 714-20
2. Weber B, Burger W, Hartmann R. Høvener G, Malchus R, Oberdisse U. Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986; 29: 23-9
3. Johnsson S. Retinopathy and nephropathy in diabetes mellitus: comparison of the effects of two forms of treatment. Diabetes 1960; 9: 1-8
4. Pirart J. Diabetes mellitus and its degenerative complications. A prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-88
5. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic nephropathy. Arch Intern Med 1994; 154: 2169-78
6. Doft BH, Kingsley LA, Orchard TF, Kuller L, Drash A, Becker D. The association between long-term diabetic control and early retinopathy. Ophthalmology 1984; 91: 763-9
7. Wiseman M, Viberti GC, Mackintosh D, Jarrett RF, Keen H. Glycaemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984; 26: 71-4
8. Bangstad H-J, Hanssen KF, Dahl-Jørgensen K, Aagenæs Ø. Microalbuminuria is associated with long term poor glycemic control in adolescent insulin dependent diabetics. Diabetes Res 1989; 12: 71-4
9. Mortensen HB, Martinelli K, Nørgaard K, Main K, Kasrup KW, Ibsen KK, et al. A nation-wide cross-sectional study or urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Diabetic Med 1990; 7: 887-97
10. Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 1049-54
11. Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabetic Med 1995; 12: 482-7
12. Keen H. Normoglycemia re-entry and diabetic complications. Diabetic Med 1984; 1: 85-7
13. Dahl-Jørgensen K. Near-normoglycemia and late diabetic complications. The Oslo Study (Thesis). Acta Endocrinol (Copenh) 1987; 115 (Suppl 284): 1-56
14. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of 2 years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986; i: 1300-4
15. Reichard Å, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-9
16. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type-1 diabetes. Lancet 1993; 341: 1306-9
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
18. Bangstad H-J, Dahl-Jørgensen K, Hartmann A, Hanssen KF. Improvement of blood glucose control retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; 37: 483-90
19. Rudberg S, Østerby R, Dahlquist G, Nyberg G, Persson B. Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 1997; 20: 265-71
20. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 1989; 86: 5141-5
21. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987: 316: 599-606
22. Williamson JR, Chang K, Tilton RC, Prater C, Jeffrey JR, Weigel C, et al. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration. Diabetes 1987; 36: 813-21
23. Bucala R, Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 1992; 23: 1-34
24. Berg TJ, Bangstad H-J, Torjesen PA, Østerby R, Bucala R, Hanssen KF. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. Metabolism 1997; 46: 661-5
25. Berg TJ, Dahl-Jørgensen K, Torjesen OA, Hanssen KF. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care 1997; 20: 1006-8
26. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenxs Ø. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus. The Oslo Study. BMJ 1985; 290: 811-5
27. Dahl-Jørgensen K, Hanssen KF, Brinchmann-Hansen O, Aker Diabetes Group. What happens to the retina as diabetic control is tightened? Lancet 1983; i: 652 (Letter)
28. Grunwald JE, Brucker AJ, Braunstein SN, Schwartz SS, Baker L, Petrig BL, et al. Strict metabolic control and retinal blood flow in diabetes mellitus. Br J Ophthalmol 1994; 78: 598-604
29. Rich SS, Freedman BI, Bowden DW. Genetic epidemiology of diabetic complications. Diabetes Rev 1997; 5: 165-73
30. Seaquist ER, Goetz FC, Rich S, Basrbosa J. Familial clustering of diabetic nephropathy. N Engl J Med 1989; 320: 1161-5
31. The DCCT Research Group. Clustering of long term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 719-22
32. Hansen PM, Chowdhury T, Deckert T, Hellgren A, Bain SC, Pociot F. Variation of the heparan sulfate proteoglycan gene (perlecan gene). Diabetes 1997; 46: 1658-9
33. Dahl-Jørgensen K, Brinchmann-Hansen O, Bangstad H-J, Hanssen KF. Blood glucose control and microvascular complications - what do we do now? Diabetologia 1994; 37: 1172-7